Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413835 | SCV000492065 | uncertain significance | not specified | 2016-11-22 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the ALG13 gene. The N435S variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The N435S variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. However, this variant was not observed in approximately 5,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000650333 | SCV000772176 | likely benign | Developmental and epileptic encephalopathy, 36 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000413835 | SCV005621655 | benign | not specified | 2024-11-05 | criteria provided, single submitter | clinical testing |